Market and Patient Access – Full SpotlightPublished: September 6, 2019
GUEST EDITOR: Lee Buckler, President & CEO, RepliCel Life Sciences Inc
Recent product approvals have only increased the sense of urgency to find viable pricing and reimbursement models for cell & gene therapies. They have also brought into sharper focus the need to educate and work with a wide variety of healthcare sector stakeholders – and of course, patients themselves – to ensure society benefits fully from such novel, disruptive therapeutic technologies.
You can download the full Spotlight on Patient and Market Access free of charge – simply login or register here to become a member